SARS-CoV-2 Viral Replication in a High Throughput Human Primary Epithelial Airway Organ Model
Fisher, C. R.; Medie, F. M.; Luu, R. J.; Gaibler, R.; Miller, C. R.; Mulhern, T. J.; Vijayakumar, V.; Marr, E.; Alladina, J.; Medoff, B.; Borenstein, J. T.; Gard, A. L.
Show abstract
COVID-19 emerged as a worldwide pandemic early in 2020, and at this writing has caused over 170 million cases and 3.7 million deaths worldwide, and almost 600,000 deaths in the United States. The rapid development of several safe and highly efficacious vaccines stands as one of the most extraordinary achievements in modern medicine, but the identification and administration of efficacious therapeutics to treat patients suffering from COVID-19 has been far less successful. A major factor limiting progress in the development of effective treatments has been a lack of suitable preclinical models for the disease, currently reliant upon various animal models and in vitro culture of immortalized cell lines. Here we report the first successful demonstration of SARS-CoV-2 infection and viral replication in a human primary cell-based organ-on-chip, leveraging a recently developed tissue culture platform known as PREDICT96. This successful demonstration of SARS-CoV-2 infection in human primary airway epithelial cells derived from a living donor represents a powerful new pathway for disease modeling and an avenue for screening therapeutic candidates in a high throughput platform.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure-function relationships of mucociliary clearance in human and rat airways 94%
- Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue 94%
- Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology 93%
Similar papers in this journal
- Cryobanking of human distal lung epithelial cells for preservation of their phenotypic and functional characteristics. 94%
- Targeting ATP12A, a non-gastric proton pump alpha subunit, for idiopathic pulmonary fibrosis treatment 93%
- A Micro-Engineered Airway Lung-Chip Models Key Features of Viral-Induced Exacerbation of Asthma 93%
Similar papers in this journal
- Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19 93%
- Dissolved gases from pressure changes in the lungs elicit an immune response in human peripheral blood 92%
- Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variants 90%
Similar papers in this journal
- Nebulized 2-deoxylated glucose analogues inhibit respiratory viral infection in advanced in vitro airway models 95%
- Epithelial Remodeling And Microbial Dysbiosis In The Lower Respiratory Tract Of Vitamin A-Deficient Mouse Lungs 93%
- Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2 93%
Similar papers in this journal
- Culture Conditions Differentially Regulate the Inflammatory Niche and Cellular Phenotype of Tracheo-Bronchial Basal Stem Cells 94%
- Standardized pipeline for establishing, expanding, and differentiating airway and alveolar organoids from human BAL fluid 93%
- Receptor agonist of NFκB signaling ligand directs lung epithelial cell expansion through RANK signaling 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.